Infinity Pharmaceuticals Inc Company Information
Employees at Infinity Pharmaceuticals Inc
Showing 12 of 596| JOB TITLE | WORK EMAIL | WORK PHONE | LOCATION | |
|---|---|---|---|---|
| Lead Senior Scientist | @infi.com | - |
Boston, Massachusetts | VIEW PROFILE |
| Project Manager / Lead Senior Analyst | @infi.com | - |
Boston, Massachusetts | VIEW PROFILE |
| Senior Legal Assistant | @infi.com | +1 (617) 453-xxxx | Cambridge, Massachusetts | VIEW PROFILE |
| Employee | @blueslate.net | - |
Albany, New York | VIEW PROFILE |
| Employee | @infi.com | - |
VIEW PROFILE | |
| Senior Clinical Trial Associate | @infi.com | - |
Boston, Massachusetts | VIEW PROFILE |
| Clinical Research Intern | @infi.com | - |
Glendale, Arizona | VIEW PROFILE |
| Clinical Trail Associate | @infi.com | - |
Boston, Massachusetts | VIEW PROFILE |
| Clinical Outsourcing Intern | @infi.com | - |
Westborough, Massachusetts | VIEW PROFILE |
| Qc Scientist | @infi.com | - |
Philadelphia, Pennsylvania | VIEW PROFILE |
| Senior Director Regulatory Affairs Cmc | @infi.com | - |
Cambridge, Massachusetts | VIEW PROFILE |
| Clinical Data Associate | @infi.com | - |
New York, New York | VIEW PROFILE |
Employee
Albany, New York 
Enter an employee name to search and verify work emails, phone numbers and social links etc.
Infinity Pharmaceuticals Inc's Email Format
We found 7 email formats used by Infinity Pharmaceuticals Inc employees. The most common Infinity Pharmaceuticals Inc email format is first.last ex.(jane.doe@infi.com) being used 81% of the time.
| FORMAT | % | ||
|---|---|---|---|
| First.last | jane.doe@infi.com | 81% | |
| Others | @infi.com | 5% | |
| Last | doe@infi.com | 4% | |
| First_initial.last | j.doe@infi.com | 3% | |
| First_initial Last | jdoe@infi.com | 2% | |
| First | jane@infi.com | 1% | |
| Middle.last | emily.doe@infi.com | 1% |
first.last
jane.doe@infi.com
81%
others
@infi.com
5%
last
doe@infi.com
4%
first_initial.last
j.doe@infi.com
3%
first_initial last
jdoe@infi.com
2%
first
jane@infi.com
1%
middle.last
emily.doe@infi.com
1%
